Furthermore, we found NCI-H929 cells with BCMA knockout became unresponsive to BCMA CAR-T cells, yet remained highly susceptible to recognition and killing by FcRH5 CAR-T cells as demonstrated both in vitro and in the xenograft tumor model. The gene discussed is FCRL5; the disease is neoplasm.